Furthermore, we discovered that PD-L1 expression increased after PTK6 knockdown in lung adenocarcinoma cell lines, and the cohort survival analysis with immunotherapy suggested that T-cell number in the immune microenvironment does not determine the effect of immunotherapy, but rather T-cell function does. The gene discussed is PTK6; the disease is lung adenocarcinoma.